TRIPLET THERAPEUTICS

triplet-therapeutics-logo

Triplet is developing transformative therapies that treat repeat expansion disorders at their source.

#SimilarOrganizations #People #Financial #Event #Website #More

TRIPLET THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care

Founded:
2019-01-01

Address:
Cambridge, Massachusetts, United States

Country:
United States

Website Url:
http://www.triplettx.com

Total Employee:
1+

Status:
Active

Contact:
781.299.7830

Email Addresses:
[email protected]

Total Funding:
59 M USD

Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Google Font API Google Maps SSL By Default IPv6 Cloudflare Hosting Google Maps API Cloudflare CDN


Similar Organizations

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

kodiak-sciences-logo

Kodiak Sciences

Kodiak is designing and developing novel therapies for the treatment of retinal disease.

kytopen-logo

Kytopen

Kytopen developer of a cell therapy platform for non-viral delivery of molecules into hard-to-transfect immune cells.

metis-therapeutics-logo

METiS Therapeutics

METiS Therapeutics uses integrated drug discovery to develop medicines in a variety of illness areas.

rome-therapeutics-logo

ROME Therapeutics

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

vedere-bio-ll-logo

Vedere Bio ll

Vedere Bio is developing gene therapy products to restore functional vision to patients who have suffered vision loss.

Current Employees Featured

nessan-bermingham_image

Nessan Bermingham
Nessan Bermingham Founder, CEO & currently Exec Chair @ Triplet Therapeutics
Founder, CEO & currently Exec Chair
2018-10-01

alan-j-buckler_image

Alan J. Buckler
Alan J. Buckler Chief Scientific Officer @ Triplet Therapeutics
Chief Scientific Officer
2020-07-01

Founder


nessan-bermingham_image

Nessan Bermingham

Investors List

invus_image

Invus

Invus investment in Series A - Triplet Therapeutics

mpm-capital_image

MPM Capital

MPM Capital investment in Series A - Triplet Therapeutics

atlas-venture_image

Atlas Venture

Atlas Venture investment in Series A - Triplet Therapeutics

pfizer-venture-investments_image

Pfizer Venture Investments

Pfizer Venture Investments investment in Series A - Triplet Therapeutics

alexandria-venture_image

Alexandria

Alexandria investment in Series A - Triplet Therapeutics

partners-innovation-fund_image

Partners Innovation Fund

Partners Innovation Fund investment in Series A - Triplet Therapeutics

atlas-venture_image

Atlas Venture

Atlas Venture investment in Seed Round - Triplet Therapeutics

Key Employee Changes

Date New article
2020-07-23 Triplet Therapeutics nabs Scholar Rock R&D exec as new CSO

Official Site Inspections

http://www.triplettx.com

  • Host name: 172.67.131.200
  • IP address: 172.67.131.200
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Triplet Therapeutics"

Triplet Therapeutics - Crunchbase Company Profile

Organization. Triplet Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number 781.299.7830; Lists Featuring This …See details»

Triplet Therapeutics Launches with $59 Million in Financing to …

CAMBRIDGE, Mass., Dec. 17, 2019 – Triplet Therapeutics, Inc., a biotechnology company harnessing human genetics to develop treatments for repeat expansion disorders at their …See details»

Triplet Therapeutics - PitchBook

Triplet Therapeutics General Information Description. Developer of transformative therapies designed to treat repeat expansion disorders at the source. The company's therapies …See details»

Triplet Therapeutics - VentureRadar

"OUR FOCUS;Triplet Therapeutics is an early stage start-up biotherapeutics company developing new therapeutic approaches to address triplet repeat disorders such as Huntington’s disease …See details»

Triplet Therapeutics: Contact Details and Business Profile

Triplet Therapeutics is a biotechnology company developing transformational treatments for patients with repeat expansion disorders (REDs) -- a group of more than 50 known genetic …See details»

Triplet Therapeutics Company Profile | Management and

Www.triplettx.com Triplet Therapeutics Profile and History Founded in 2018, Triplet Therapeutics is a biotechnology company focused on developing treatments for expansion disorders.See details»

Triplet Therapeutics - Craft

Triplet Therapeutics is a company that develops biotherapeutic compounds designed to treat repeat expansion disorders. Its biotherapeutics technology provides treatment for repeat …See details»

Triplet Therapeutics - Overview, News & Similar companies

Mar 25, 2021 Triplet Therapeutics to Present at Stifel Virtual Healthcare Conference CAMBRIDGE, Mass.--(BUSINESS WIRE)--Triplet Therapeutics, Inc., a biotechnology …See details»

Triplet Therapeutics Inc. Company Profile -Sales, Contacts, …

Triplet Therapeutics is in the Biological Research industry within the Engineering, Accounting, Research, and Management Services sector and has been in business for approximately 6 years.See details»

Triplet Therapeutics - Wiki - Golden

A therapeutics company developing siRNA and ASO therapeutics that target repeat expansion disorders such as Huntington’s disease, myotonic dystrophy and spinocerebellar ataxiasSee details»

Triplet Therapeutics Appoints Alan Buckler, Ph.D., as Chief …

Jul 23, 2020 Buckler serves on the Scientific Advisory Board of the Hereditary Disease Foundation, a nonprofit organization committed to funding innovative research into treatments …See details»

Triplet Therapeutics, Inc. | CipherBio

Explore Triplet Therapeutics, Inc.'s investment information, scientific platforms, therapeutic approaches, indications and more here!See details»

Triplet Therapeutics - ataxia-global-initiative

Description Triplet Therapeutics is leveraging insights from human genetics to develop therapies targeting the underlying cause of repeat expansion disorders (REDs), a group of more than 50 …See details»

Triplet Therapeutics Initiates SHIELD HD Natural History Study of ...

May 27, 2020 For more information, please visit www.triplettx.com. Contacts. Mary Carmichael Ten Bridge Communications [email protected] 617-413-3543 Release …See details»

Triplet Therapeutics - VentureRadar

Similar Companies: Peaccel France Privately Held PEACCEL “The AI company for Life Sciences” offers an innovative unique and versatile AI-platform named innov’SAR that allows predicting …See details»

Букмекер и казино Мостбет: официальный сайт и рабочее …

Букмекер и казино Мостбет в Узбекистане⚡предлагает каждому побороться за выигрыши в слотах и ставках на спорт бесплатно: оператор регулярно предлагает промокоды на …See details»

Home - V2X

Empowering an Agile Workforce. V2X delivers managed learning solutions worldwide that engage, educate, and ensure your people and your business can thrive in a fast-evolving …See details»

Global X Files Preliminary Prospectus, Seeking to Launch

1 day ago Organization Profile. Global X Investments Canada Inc. Global X Investments Canada Inc. is an innovative financial services company and offers one of the largest suites of …See details»

Our Leadership & Governance Team | LATICRETE

2000+ Team Members, 100 Countries, 65+ Years of Innovation, 6 Continents, 3 Generations, 1 Family. LATICRETE International, Inc. was founded in 1956 by the late Dr. Henry M. RothbSee details»

Delta-T Group

Just beginning a career within the education, social service, behavioral health, disability sector or already have many years of experience? Delta-T Group has the referrals to help you further …See details»

linkstock.net © 2022. All rights reserved